Top Wall Street analysts changed their prospects on these top names. See our Page Analyst Ratings page for a complete picture of all changes in the analysts, including upgrades, downgrades and initiations.
- Jefferies analyst Julien Dumoulin-Smith downgraded Sunrun Inc. Run From waiting to underperform and reduced the price target from $ 6 to $ 5. Sunrun shares closed on Tuesday at $ 8.86. See how other analysts view this stock.
- BairD analyst Michael HA has lowered the rating for UnitedHealth Group Incorporated Ultra From outperform to neutral and reduced the price target from $ 356 to $ 312. UnitedHealth shares were closed on Tuesday for $ 303.79. See how other analysts view this stock.
- Goldman Sachs analyst Kash Rangan lowered Gitlab Inc. GTLB From buying to neutral and lowers the price target from $ 63 to $ 50. Gitlab shares are closed on Tuesday for $ 48.51. See how other analysts view this stock.
- Morgan Stanley analyst Keith Weiss downgraded Bill Holdings, Inc. Account From overweight to the same weight and reduced the price target from $ 60 to $ 55. Bill Holdings shares were closed on Tuesday for $ 45.37. See how other analysts view this stock.
- D. Boral Capital analyst Jason Kolbert has reduced the rating for Artelo Biosciences, Inc. Artl From buying to hold. Artelo Biosciences Shares were closed on Tuesday for $ 1.13. See how other analysts view this stock.
Consider buying UNH stock? This is what analysts think:
- Massive demand and disruptive potential – Boxabl has been interested in more than 190,000 houses and positions itself as a great disturbed in the housing market.
- Revolutionary production approach -Inspired by Henry Ford’s assembly line, the foldable small houses of Boxabl are designed for much efficient production, making homeowners more accessible.
- Affordable investment opportunity – With houses priced at $ 60,000, Boxabl collects $ 1 billion to scale up production, and offers investors the opportunity to have an interest in its growth.
Read this following:
Photo via Shutterstock
Market news and data offered by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
#analyst #UnitedHealth #Group #longer #Bullish #top #downgrades #Wednesday #Artelo #Biosciences #Nasdaq #Artl #Bill #Holdings #NYSE #BILL